|
Patients (n=68)
|
Patients (n=68)
|
Controls (n=75)
|
Controls (n=75)
|
Group
Comparison
|
Variable
|
Mean or percentage
|
SD
|
Mean or
percentage
|
SD
|
p
|
Age at test (years) |
39.1 |
10.1 |
36.2 |
11.3 |
.11 |
Gender (% Male) |
79 |
|
65 |
|
.06 |
Age of First Hospitalization (years) |
23.1 |
7.8 |
|
|
|
Visual Acuity (logMAR) |
.05 |
.09 |
-.06 |
.09 |
<.001 |
Participant Socioeconomic Status (SES)1
|
25.5 |
11.5 |
41.7 |
10.7 |
<.001 |
Parent Socioeconomic Status (SES)1
|
50.8 |
27.1 |
44.3 |
14.7 |
.11 |
Illness duration (years) |
15.7 |
9.03 |
|
|
|
Chlorpromazine equivalents (mg/day) |
901.5 |
694.9 |
|
|
|
PANSS, positive |
19.6 |
6.0 |
|
|
|
PANSS, negative |
17.9 |
4.2 |
|
|
|
PANSS, general psychopathology |
35.4 |
6.2 |
|
|
|